Rep. Anna Eshoo (D-CA) (Graeme Sloan/AP Images)
June 23, 2022 12:17 PM EDTUpdated 12:58 PM
FDA+
Law

Fight over where to house ARPA-H still brews with House bil­l's pas­sage

Zachary Brennan

Senior Editor

The Biden ad­min­is­tra­tion isn’t back­ing down from its de­sire to keep a new drug ac­cel­er­a­tor, known as ARPA-H, in­side the Na­tion­al In­sti­tutes of Health. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times